癌症切片檢查市場按產品類型和切片檢查類型分類

Cancer Biopsy Market, By Product, Biopsy Type -

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年癌症切片檢查市場規模估計為 336.9 億美元，預計到 2032 年將達到 879.9 億美元，2025 年至 2032 年的年複合成長率為 14.7%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	336.9億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的年複合成長率	14.70%	2032年價值預測	879.9億美元

切片檢查是一種醫學檢查，需要從體內取出組織或細胞樣本，並在實驗室進行檢查。另一方面，癌症切片檢查需要從患者體內採集組織或細胞，以發現癌症的存在、原因和程度。因此，隨著全球癌症負擔的加重，切片檢查或切片檢查的使用也在快速成長。

市場動態

腫瘤疾病盛行率的不斷上升、人口老化加劇、液體切片檢查的出現和採用、人們對基因檢測和遺傳性腫瘤疾病認知的不斷提高以及切片檢查技術的不斷發展是預計將促進全球切片檢查市場成長的關鍵因素。

例如，2022年5月，德爾菲診斷公司（Delfi Diagnostics）宣布了其新一代液態切片平台的多項應用。德爾菲診斷公司是一家開發用於早期癌症檢測的新型高性能、低成本液態切片檢測方法的公司。德爾菲提供了其正在進行的DELFI-L101測試的最新進展，這是一項前瞻性病例對照研究，旨在訓練和測試用於肺癌檢測的分類器。

研究的主要特點

本報告對全球切片檢查市場進行了詳細分析，並提供了預測期 2025-2032（以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
該報告涵蓋了全球切片檢查市場的主要企業概況，基於以下參數，例如公司亮點、產品系列、關鍵亮點、績效和策略。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
本研究報告針對該產業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過全球切片檢查市場分析中使用的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 33.69 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.70%	2032 Value Projection:	USD 87.99 Bn

A biopsy is a medical test to remove the piece of tissue or a sample of cells from the body so that it can be tested in a laboratory. While, in cancer biopsy, a tissue or cells of the affected patient is taken to discover the presence, cause, or extent of cancer. Thus, with the rising burden of cancer across the globe, the use of cancer biopsy or cancer biopsies also increasing with a rapid pace.

Market Dynamics:

Increasing prevalence of oncology disorders, growing geriatric population, advent of liquid biopsy or increasing adoption of liquid biopsies, increasing awareness among people about genetic testing and inherited oncology diseases, and ongoing developments in biopsy techniques are major factors expected to augment the growth of the global cancer biopsy market.

For instance, in May 2022, Delfi Diagnostics, a developer of a new class of high-performance and affordable liquid biopsy tests for early cancer detection, presented multiple applications for its next-generation liquid biopsy platform. Delfi presented a trial-in-progress update on DELFI-L101, a prospective, case-control study to train and test classifiers for lung cancer detection.

Key features of the study:

This report provides in-depth analysis of the global cancer biopsy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cancer biopsy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include QIAGEN, Illumina, Inc., Angle PLC, Myriad Genetics, COUNSYL, Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher, F. Hoffmann-La Roche Ltd., Epigenomics AG, BD (Becton, Dickinson and Company), and Helio Health (Laboratory for Advanced Medicine), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cancer biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer biopsy market.

Detailed Segmentation:

Global Cancer Biopsy Market , By Product:
- Instruments
- Kits and Consumables
- Services
Global Cancer Biopsy Market , By Biopsy Type:
- Tissue Biopsy
- Needle Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
- Liquid Biopsy
- Others
Global Cancer Biopsy Market, By Application:
- Breast Cancer
- Colorectal Cancer
- Cervical Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Blood Cancer
- Kidney Cancer
- Liver Cancer
- Pancreatic Cancer
- Ovarian Cancer
- Others
Global Cancer Biopsy Market , By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- QIAGEN
- Illumina, Inc.
- Angle PLC
- Myriad Genetics
- COUNSYL, Inc.
- Hologic, Inc.
- Biocept, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher
- Hoffmann-La Roche Ltd.
- Epigenomics AG
- BD (Becton, Dickinson and Company)
- Helio Health (Laboratory for Advanced Medicine)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Biopsy Type
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rising burden of oncology disorders
- Technical and clinical challenges
- Increasing adoption of liquid biopsies
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Cancer Biopsy Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cancer Biopsy Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Kits and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Cancer Biopsy Market, By Biopsy Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tissue Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Needle Biopsy
- Fine Needle Aspiration (FNA)
- Core Needle Biopsy (CNB)
Liquid Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Cancer Biopsy Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cervical Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Skin Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ovarian Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Cancer Biopsy Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Biopsy Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)

9. Competitive Landscape

QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Angle PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
COUNSYL, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biocept, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Epigenomics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BD (Becton, Dickinson and Company)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Helio Health (Laboratory for Advanced Medicine)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views